# Serum Galectin-3 as a Marker of Human Papillomavirus Infection

> **NCT06005389** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 100 (actual)

## Conditions studied

- Human Papillomavirus Infection

## Interventions

- **PROCEDURE:** cryotherapy
- **DIAGNOSTIC_TEST:** serum Galectin-3 assay

## Key facts

- **NCT ID:** NCT06005389
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005389, "Serum Galectin-3 as a Marker of Human Papillomavirus Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06005389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*